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Abstract
The reproducibility of macular pigment optical density (MPOD) estimates in the elderly was assessed in 40 subjects (age:
79.1 § 3.5). Test–retest variability was good (Pearson’s r coeYcient: 0.734), with an average coeYcient of variation (CV) of 18.4% and
an intraclass correlation coeYcient (ICC) of 0.96. The eVect of optical blur on MPOD estimates was investigated in 22 elderly pseudo-
phakic subjects (age: 79.9 § 3.6) by comparing the baseline MPOD, obtained with an optimal correction, with MPODs obtained with
a §1.00-diopter optical blur. This optical blur did not cause diVerences in the MPOD estimates, its accuracy, or test duration.
© 2007 Elsevier Ltd. All rights reserved.
Keywords: Macular pigment optical density; Heterochromatic Xicker photometry; Reliability; Optical blur; Aging1. Introduction
The determination of macular pigment optical density
(MPOD) has been the object of increasing interest in the
last decade and several methods to estimate it have been
developed (Berendschot & van Norren, 2004; Bernstein,
Zhao, Sharifzadeh, Ermakov, & Gellermann, 2004; Bone
& Landrum, 2004; Davies & Morland, 2004; Delori, 2004;
Moreland, 2004). The method that relies on the principle
of heterochromatic Xicker photometry (HFP) provides a
psychophysical estimate of MPOD (Bone & Landrum,
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doi:10.1016/j.visres.2007.01.0132004; Snodderly & Hammond, 1999), and has emerged as
the most widely utilized to date. HFP-based estimates of
MPOD have been used as a method to understand the
biological determinants of the retinal contents in the mac-
ular pigments, lutein and zeaxanthin (Beatty et al., 2001;
Bone & Landrum, 2004; Hammond, Wooten, & Snod-
derly, 1998; Snodderly et al., 2004), and have the potential
to develop into an outcome measure in longitudinal
observational and interventional studies of macular aging
and degeneration.
Validity and reliability are two fundamental
properties of any measurement method. In the absence of
an alternative gold-standard method for MPOD measure-
ments, it remains a matter of debate which of the various
MPOD measurement methods that have been thus
far developed may be the best or the most accurate
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mond, 2003a, 2003b; Berendschot & van Norren, 2004;
Berendschot & van Norren, 2005; Bernstein et al., 2004;
Bone & Landrum, 2004; Davies & Morland, 2004; Delori,
2004; Moreland, 2004). The spectral properties of the
macular pigments, though, are well known and various
studies on the validity of the HFP-based determinations
based on responses at diVerent wavelengths have been
published (Bone, Landrum, & Cains, 1992; Bone & Lan-
drum, 2004; Snodderly, Brown, Delori, & Auran, 1984;
Snodderly & Hammond, 1999; Snodderly et al., 2004;
Wooten, Hammond, Land, & Snodderly, 1999). Likewise,
studies of dietary lutein supplementation have docu-
mented its eVect on MPOD in both normal (Berendschot
et al., 2000; Hammond et al., 1997; Johnson et al., 2000;
Koh et al., 2004; Landrum et al., 1997) and diseased eyes
(Aleman et al., 2001; Duncan et al., 2002; Koh et al.,
2004), further attesting to its validity. Therefore, there is
presently little doubt that this method provides a genuine
estimate of MPOD.
On the other hand, the test–retest reliability of MPOD
psychophysical determinations, i.e., the ascertainment of
the reproducibility of a given measurement on the same
subject at two distinct points in time, has not been equally
investigated. Studies that have formally characterized test–
retest reliability in the elderly are particularly limited in
number. To the best of our knowledge, the only study that
addressed this issue speciWcally is that of Snodderly et al.
(2004), which showed high reproducibility in women
between the age of 50 and 79. We recently completed a
cross-sectional study on a large biracial sample of elderly
subjects from the Memphis metropolitan area participating
in the Age-Related Maculopathy Ancillary (ARMA)
Study, most of whom were also participants in the prospec-
tive Health, Aging, and Body Composition (Health ABC)
Study. The strategies that have been utilized to develop a
simpliWed testing protocol more suitable for utilization of
the HFP-based method in the elderly and information on
the MPOD in this population sample have been recently
published (Iannaccone et al., 2007). Here, we present our
test–retest reliability data on a sample of the ARMA Study
participants over a decade older than in any previous
assessment. This is particularly relevant because of the very
high occurrence of ARM in this age range (Friedman et al.,
2004).
In addition to ARM, also cataract and pseudophakia
are highly prevalent among the elderly. By age 75, it has
been estimated that over 50% of all Americans will develop
cataracts (Congdon et al., 2004). Likewise, presbyopia is
another phenomenon that is well known to occur with
aging (Croft, Glasser, & Kaufman, 2001; Glasser, Croft, &
Kaufman, 2001; Koretz, Kaufman, Neider, & Goeckner,
1989; Krag & Andreassen, 2003; Strenk, Strenk, & Koretz,
2005). While the use of multifocal and pseudo-accommo-
dating intraocular lenses (IOLs) is on the rise, traditional
monofocal IOLs are still widely used and highly prevalent
in the population, invariably requiring post-operative spec-tacle correction to focus sharply at near. It has already been
shown that MPOD can be reliably estimated in elderly sub-
jects despite dense cataracts, and that subsequent IOL
implantation does not lead to MPOD estimates diVerent
than baseline ones (Ciulla, Hammond, Yung, & Pratt,
2001). However, to the best of our knowledge, no formal
studies of the eVects of optical blur on MPOD determina-
tions have been conducted, and speciWcally not in subjects
post-IOL implantation, to understand if pseudophakic sub-
jects may require particular precision in spectacle correc-
tion at near for more reliable and/or accurate MPOD
testing. Preliminary results of this work have been reported
in poster format (Gallaher et al., 2005; Iannaccone et al.,
2005).
2. Methods
2.1. Study population
The ARMA Study focused primarily on a sample of participants in the
Health ABC study, which consists of a biracial cohort of over 3000 highly
functional elderly individuals 70 years old or older at study inception.
Health ABC is being conducted at two US sites, Memphis, TN, and Pitts-
burgh, PA. Our study included a large biracial sample of men and women
from the Memphis cohort (n D 340), on average 79 years old. A sample of
the ARMA study participants took part in this sub-study. Other details
about the ARMA Study population have been provided elsewhere (Ian-
naccone et al., 2007). All procedures conformed to the Declaration of Hel-
sinki and the study was approved by the Institutional Review Board of the
University of Tennessee Health Science Center.
2.2. General MPOD measurement methodology
A commercially available HFP instrument (Macular Metrics Corp.,
Rehoboth, MA) based on the one developed by, and reported in Wooten
et al. (1999), was used to measure the MPOD in our study. Only the 0.5-
deg eccentricity target was used in this study for foveal determinations.
Further details about our simpliWed testing protocol and its speciWc fea-
tures have been recently published (Iannaccone et al., 2007). During the
test, all subjects wore their best correction. The instrument has a default
+1.50 D lens, mounted in front of the chin- and headrest, through which
subjects observe the test targets. Typically, subjects with intact accommo-
dation at near will not require any additional correction to see the test tar-
gets sharply, and we veriWed this to be the case in a small pre-study
assessment sample of younger subjects (unpublished data). However, sev-
eral of these younger participants reported a subjective impression of
increased uncertainty in the identiWcation of the limits of the no-Xicker
zone, especially with the +1.00 D blurring lens. Therefore, we reasoned
that in elderly individuals, and especially pseudophakic ones, the default
correction may have not always allowed the sharpest possible perception
of the test targets. This could potentially result in suboptimal sharpness of
the test targets, increased diYculties in some subjects with the test task,
and possibly increased test duration and/or variability. Hence, to make
sure that blurry perception of the targets did not jeopardize the outcome
of our estimates, we determined systematically the correction in addition
to the default +1.50 D one, if any, that allowed participants to detect the
edges of a ring test target (1.0-deg eccentricity) the sharpest, and per-
formed MPOD estimations throughout the study with any such supple-
mental correction in place. These corrections were used as the baseline
optimal correction towards which the optical blur study was conducted
(see below).
With our simpliWed testing protocol (Iannaccone et al., 2007), we
asked participants to identify the lower and the upper limits of the
no-Xicker (null) zone, which we termed the minimum and the maximum
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lated the exact average of these two values as the middle of the no-Xicker
zone, and entered it on the subjects’ behalf. By using this protocol, we have
shown that we could limit test repetitions to only three per target. Addi-
tional details have been reported elsewhere (Iannaccone et al., 2007).
2.3. Test–retest variability assessment
MPOD test–retest variability was assessed in a sample of 40 healthy
subjects (age: 79.1 § 3.5 years old; range: 69–84). Of these, 25 (63%) were
females, 36 (90%) Caucasians, and 18 (45%) were on lutein-containing
supplements. In order to gain insight into both short- to mid-term vari-
ability as well as long-term variability of the MPOD estimates, retests were
performed over a wide range of inter-test time intervals, ranging from as
little as one week to as much as approximately 20 months (<6 months,
n D 22). Successful completion of a baseline MPOD testing session in at
least one eye and self-reported absence of changes in vision, eye health or
status (e.g., cataract surgery between sessions) in response to a custom-
designed questionnaire administered by study staV were required to be
eligible for this test–retest variability study. Prospective retest subjects
were approached for retest subsequent to the baseline session (same day or
later by phone). In addition to these criteria, which were met by all retest
participants, subjects approached to return after 78 weeks from baseline
testing (n D 26) were eligible only if they had maintained the same dietary
and drinking patterns, had not in the meantime started the use of lutein-
containing supplements or changed the dosage thereof, and had not expe-
rienced signiWcant general health-related events that could have otherwise
modiWed their nutritional status and/or their ability to absorb carotenoids
(e.g., cancer, or surgery of the gastrointestinal or biliary tract). This infor-
mation was obtained from all subjects by study staV.
2.4. Optical blur assessment
The eVect of optical blur was investigated in 22 healthy pseudophakic
subjects (age: 79.9 § 3.6 years old; range: 69–84), 15 of whom were females
(68%), 20 Caucasians (91%), and seven (32%) lutein-containing supple-
ment users since baseline. For this purpose, we compared the baseline
MPOD, obtained with the optimal correction determined as described
above, with MPODs obtained in the presence of a §1.00 D optical blur.
All participants were tested Wrst with their optimal correction, and then
adding a +1.00 D and a ¡1.00 D defocusing lens. All but four of these par-
ticipants (82%) identiWed the default +1.50 D lens as the optimal one. The
four participants who preferred supplemental correction required the
addition of +0.50 D (n D 1) or +1.00 D (n D 3) spherical correction to
achieve optimal perception of the ring test target. This is representative of
both the proportion of subjects asking for supplemental correction and
the amount of correction needed (never more than +1.25 D) throughout
the main study (unpublished observation).
All subjects participating in this sub-study were retested on the same
day. Therefore, to minimize confounding from a systematic learning eVect
on the estimate of the impact of the two types of the blurring experimental
conditions, repeat testing with the defocusing lenses was performed with
an alternate plus/minus and minus/plus lens order on every other partici-
pant, so that approximately half of the sample had the +1.00 D (n D 11)
and the other half the ¡1.00 D lens (n D 10) used Wrst, respectively. In
order to determine if optical blur increased the variance around the mean
of the MPOD estimates and therefore diminished its precision, the SD of
each estimate (provided automatically by the instrument) was also used to
perform comparisons across the three testing conditions. Lastly, to under-
stand if optical blur had an eVect on test duration, test duration was
monitored and recorded at the end of each testing session and compared
across conditions.
2.5. Statistical methods
To determine if there was a signiWcant diVerence in baseline and
retest MPOD measurements, a two-tailed paired Student’s t-test wasused. To determine the level of correlation between the Wrst and the
second measure, the Pearson’s r coeYcient of correlation was calcu-
lated. Lastly, to obtain an estimate of the within-subject variability
between measurements, two measures were obtained (Armstrong,
White, & Saracci, 1992): the coeYcient of variation (CV), and the
intraclass correlation coeYcient (ICC), estimated via a one-way analy-
sis of variance (ANOVA) for random eVects. A low CV and a high ICC
are indicative of high reproducibility—i.e., reliability—of the measure-
ment in question (Armstrong et al., 1992). Independent of the CV, a
high ICC is also expression of the eVectiveness of a measure in discrim-
inating between subjects (Armstrong et al., 1992). Lastly, to ensure that
the repeatability of our test results fell within 2 SDs of the average
diVerence in MPOD readings between sessions and to determine if any
systematic trend could be detected across the range of measured
MPODs, a Bland–Altman plot of the test–retest data was also gener-
ated (Bland & Altman, 1986). The question whether the length of the
test–retest time interval or the baseline MPOD values correlated with
increased variability in the test estimates was approached with a gen-
eral linear model. Since neither the test–retest interval time nor the CV
were normally distributed, they were transformed in their natural log
values for these analyses.
To determine if there was an eVect of optical blur on the MPOD esti-
mates, on the variance of each estimate, or on test duration, results for the
optical blur subgroup were compared across the three test conditions also
with a one-way ANOVA. Lastly, to understand if repeated testing on a
given day would lead to a systematic and appreciable learning eVect that
would result in a change in any of the three aforementioned variables
despite the optical blur, we re-ranked the sessions by chronological order
(baseline being always session no. 1) and re-analyzed the resulting values
accordingly.
3. Results
3.1. Test–retest variability
In the 40 healthy elderly subjects in whom MPOD esti-
mates were obtained on two distinct sessions, there was
good test–retest correlation (Pearson’s r coeYcient:
0.734). The average CV in this sample was 18.4%. The
ICC was estimated to be 0.96. The baseline MPOD of the
subjects who participated in this sub-study was represen-
tative of a wide range (0.06–0.87; mean § SD:
0.41 § 0.23). On average, MPOD at retest was virtually
identical (0.42 § 0.23) and the mean change compared to
baseline was ¡0.01 § 0.16 (p D 0.775 for paired Student’s
t-test). Visual inspection of the data plotted in Fig. 1
shows that, in the majority of the subjects, MPOD values
between sessions were within §0.1 units of each other
(dashed lines around the diagonal midline) and virtually
all of them well within §0.2 units, whereas two subjects
were obvious outliers. Nine of the 40 participants had a
CV >20%, whereas in all other cases the CV ranged from
as little as 1.3 to as much as 18.1 (in 19 of the 40 subjects,
CV <10%).
The agreement between the baseline and the retest
MPODs is illustrated in Fig. 2. Thirty-seven of 39 partici-
pants were well within the 2 SD limit. One subject was a
clear outlier (same as in Fig. 1, bottom right-hand corner),
while the other was right at the edge of the ¡2 SD limit.
There was also no evidence of any systematic relationship
between test–retest diVerences and the average of the mea-
sured MPOD values, or of any consistent bias.
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stand the reasons for such marked variability in the nine
subjects with a CV >20%. Older age was not an explanatory
variable, since the mean age of the highly variable subgroup
(79 years old) was virtually the same as the highly repro-
ducible one (78.6 years old). Likewise, there were also no
systematic diVerences in gender, race, or use of lutein-con-
taining supplements among these nine subjects (data not
shown). In some cases, individual plausible explanatory fac-
tors could be identiWed. For example, the one subject who is
Fig. 1. Scatter-plot of MPOD at baseline vs. MPOD at the retest session.
Mean § SD bars are shown for both sessions. The line of equality (solid
line) is shown for reference. The two dashed lines identify the §0.1 MPOD
unit limit. Except for two subjects (the data point in the middle of the
upper left-hand portion of the panel, and even more clearly, the one at the
bottom right-hand corner of the plot), the vast majority of the subjects
were with §0.1 units from baseline and all others were within §0.2 units.
Fig. 2. Bland–Altman plot of the diVerence between baseline and retest
MPOD and the average of these measurements. The thick dark lines iden-
tify the §2 SD limit around the mean diVerence between sessions (dashed
thin line). Except for two subjects (top and bottom of the Wgure, same sub-
jects as in Fig. 1), all subjects were within the §2 SD limits, and no trends
in the data suggestive of systematic relationships or biases across the mea-
sured MPOD range were apparent.an obvious outlier in both Figs. 1 and 2 reported on the
retest session marked diYculties in maintaining Wxation
away from the parafoveal reference target, resulting in an
MPOD estimate far lower than baseline. The other outlying
subject complained of back pain and had to re-adjust her
sitting position multiple times during the retest session,
while one additional subject with high CV was extremely
talkative during both the baseline and the retest sessions.
Both factors may have interfered with the accuracy of the
estimates. Lastly, two subjects had clinically detectable
macular RPE changes in the tested eye at baseline that did
not qualify for any grade of clear-cut ARM (AREDS cate-
gory 2) (Age-Related Eye Disease Study Research Group,
2001) and that were not associated with visual acuity
changes. It is possible that the high variability observed in
these two subjects may be expression of impending subclin-
ical macular disease. With these exceptions, we could not
document any other potential overt subject-dependent
explanatory factor for the higher than average variability
observed in those nine participants.
Test–retest time interval was not clearly related to
increased variability. Although the mean time interval was
somewhat higher in the highly variable subgroup, this
diVerence was not signiWcant (p D 0.816). Accordingly, test–
retest time interval was not correlated to the CV in the
group as a whole (Pearson’s r for the natural log of both
variables D 0.054). When examining the behavior of MPOD
estimates for subjects retested within 6 months from base-
line (n D 23), the two sessions were more closely correlated
(Pearson’s r: 0.829) than for subjects tested more than 6
months apart (Pearson’s r: 0.692; n D 17) and there was
slightly more variability in the longer-term test–retest stra-
tum (CV D 21% vs. 16%), although this diVerence was again
not signiWcant (p > 0.25 for both raw and ln-transformed
data). The CV remained unrelated to test–retest time inter-
val retested within 6 months from baseline (Pearson’s
r D 0.030). Although not statistically signiWcant (p D 0.09),
the relationship between test–retest time interval and CV in
the subjects retested more than 6 months apart was not in
the expected direction. In this group, the former tended to
be inversely related to the CV on a log–log scale (Pearson’s
r: ¡0.438), i.e., the longer the test–retest time interval, the
lower the variability. Therefore, this observation does not
help explain in any plausible fashion the increased variabil-
ity observed in those nine subjects. Lastly, there was also no
systematic direction in MPOD change in the subjects with
high CV that could suggest a speciWc trend in these subjects
either, since MPOD at the retest session diminished in four
of them and increased in Wve.
3.2. EVect of optical blur
The results of this sub-study are illustrated in Fig. 3. As
for the test–retest sample, also the MPOD of the subjects
who participated in this sub-study was representative of a
wide range (0.02–0.98). The §1 D optical blur did not cause
diVerences in the MPOD estimates (0.46 § 0.27 at baseline,
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blur, p > 0.5; Pearson’s r coeYcients of 0.890 and 0.945 for
positive and negative blur, respectively), nor did it aVect
test accuracy (MPOD variance: 5.6 £ 10¡4 at baseline,
4.9 £ 10¡4 with positive lens blur, and 6.8 £ 10¡4 with nega-
tive blur; p > 0.5 in all cases) or duration (about 15–17 min
per eye under either condition; p > 0.05).
When we re-plotted the MPOD estimates in chronologi-
cal order (i.e., from Wrst test to last regardless of the type of
blur, plots not shown), the between-session correlation
remained very high (Pearson’s r coeYcients of 0.930 and
0.901 for second and third session, respectively), but a ten-
dency towards progressively shorter test durations despite
the blur was seen (17.8 § 5.9 min at baseline, 15.6 § 5.5 for
the second test, and 14.5 § 4.1 for the third), suggestive of a
possible learning eVect. The diVerence in test duration
between the Wrst and last test sessions was of borderline sig-
niWcance (p D 0.042). There was also no between-session
diVerence in the MPOD estimates (0.45 § 0.26 at baseline,
0.46 § 0.26 on the second test, and 0.47 § 0.24 on the third)
or on in their variance (5.9 £ 10¡4 at baseline, 6.4 £ 10¡4
with positive lens blur, and 5.3 £ 10¡4 with negative blur;
p > 0.6 in all cases).
4. Discussion
To the best of our knowledge, to date the only study that
has formally addressed the issue of MPOD short-term test–
retest reliability in the elderly is that of Snodderly et al.
(2004), who studied a group of 54 elderly, mainly Cauca-
sian, highly educated women, on average 66 years old
(range: 50–79) participating in CAREDS, an ancillary
study to Women’s Health Initiative at the University of
Wisconsin, Madison site. In this study, the between-session
repeatability (CV) was, on average, between 17% and 22%.
For the entire sample retested in our study, the mean CVwas 18.4%, the ICC was very high, and very few subjects
exhibited variability within §2 SDs around the mean of the
test–retest diVerences (Fig. 2). Therefore, our Wndings are
nicely in agreement with those of Snodderly et al. (2004)
and indicate that reproducible foveal MPOD measure-
ments can be obtained in elderly subjects within a reason-
ably short testing time not only between 50 and 79 years of
age (Snodderly et al., 2004), but also well into the 8th and
9th decade of life, when the risk of ARM is highest (Fried-
man et al., 2004) and MPOD estimates for the study of
macular aging and degeneration are more likely to be used.
Possible reasons for high test–retest variability have
been identiWed in our participants. For example, the subject
whose second MPOD was most diVerent from baseline
(outlier in Figs. 1 and 2) experienced diYculties during the
retest session with maintaining Wxation away from the par-
afoveal target. Indeed, this aspect of the test was often
reported (unpublished observation) as the most challenging
of the tasks by several of the participants also in the main
study (Iannaccone et al., 2007). This Wnding suggests that
future studies should pay special attention to this proce-
dural aspect of the test, and that further improvements in
the testing methodology may help make MPOD testing an
even more patient-friendly task for all ages.
Subclinical retinal changes of possible functional signiW-
cance towards the MPOD estimates were also seen in two
subjects, but these did not correlate with the direction of
the change between sessions, nor would they correlate well
with the physical location of the MPs in the retina (Snod-
derly et al., 1984). To our knowledge, there are also no pub-
lished prospective studies of MPOD changes over time in
elderly subjects with minimal retinal changes or with early
ARM. Therefore, the signiWcance of this observation, if
any, is presently unknown.
The direction of change in the MPOD values was not
correlated to increased test–retest variability. We cannotFig. 3. Optimal correction MPOD vs. optical blur. Panel (a) shows the scatter-plot of MPOD estimates obtained with an optimal correction vs. MPOD
estimates obtained at the retest session in the presence of a +1.00 D optical blur. Panel (b) shows the same baseline data vs. MPOD estimates obtained at
the retest session in the presence of a ¡1.00 D optical blur.
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by participants with high test–retest variability was incor-
rect and that, e.g., changes in ocular status, dietary patterns,
general health, or use of lutein-containing supplements had
in fact occurred between sessions in these subjects. Lastly,
although all examiners were extensively trained and super-
vised in the course of the study, it cannot be entirely
excluded that measurement error was introduced at either
session by the examiners themselves. However, we have no
evidence to believe that data inaccuracy or technical errors
contributed to the observed variability, which is more likely
to be, in this particular age range, intrinsic to the challenges
posed to some participants by the test itself.
The results of our optical blur study also show that
MPOD testing was insensitive to a §1.00 D optical blur in
pseudophakic subjects with respect to MPOD estimates,
their variance, or the duration of the testing session. None
of the subjects who participated in this sub-study required
more than a +1.00 D correction in addition to the default
+1.50 D lens of the instrument, and the vast majority did
not require any supplemental correction. Therefore, pro-
vided that subjects are tested with their best correction at
distance in place, there appears to be no compelling
requirement for time-consuming supplemental correction
at near beyond the default one. These results further extend
the Wndings of Ciulla et al. that MPOD can be reliably mea-
sured in elderly subjects despite the presence of dense cata-
racts and that subsequent IOL implantation does not
produce signiWcant and/or systematic diVerences compared
to baseline MPOD values (Ciulla et al., 2001).
In summary, our study provided evidence that reproduc-
ible MPOD estimates can be obtained not only in elderly
women between the age of 50 and 79 years old (Snodderly
et al., 2004), but also in elderly subjects of both genders
ranging between 69 and 84 years in age. We also showed
that MPOD remains fairly stable in elderly subjects not
only in the immediate short-term but also over a relatively
extended period of time, provided that no conditions devel-
oped or dietary/supplementation pattern were changed in
the interim period. Lastly, we veriWed that MPOD estimates
by HFP are a robust measure that is insensitive not only to
the presence of lens opacities (Ciulla et al., 2001) but also to
a §1.00 D optical blur. On the aggregate, these Wndings
position well HFP-based techniques for the estimation of
MPOD for large-scale utilization also in the epidemiologic
geriatric setting.
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